Related Experiment Video
Updated: May 13, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
IL-1 and EGF regulate expression of genes important in inflammation and cancer
1Department of Cell Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland. aneta.kasza@uj.edu.pl
Abstract:
This review focuses on the mechanisms by which the expression of specific genes is regulated by two proteins that are important in inflammation and cancer, namely the pro-inflammatory cytokine interleukin (IL)-1β and epidermal growth factor (EGF). In the review the receptors that recognize factors that cause inflammation are described with main focus on the receptors associated with activation of IL-1β. The function of IL-1β and pathways leading to activation of transcription factors, particularly NFκB and Elk-1 are analyzed. Then the mechanisms of EGF action, with particular emphasis of the activation of Elk-1 are illustrated. The link between aberrant signaling of EGF receptor family members and cancer development is explained. The relationship between inflammation and tumorigenesis is discussed.
Insights
This review explores how interleukin-1 beta (IL-1β) and epidermal growth factor (EGF) regulate gene expression, impacting inflammation and cancer. It details their signaling pathways and links to tumorigenesis.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- Inflammation and cancer are complex processes involving intricate molecular signaling.
- Interleukin-1 beta (IL-1β) and epidermal growth factor (EGF) are key mediators in these pathways.
- Understanding their regulatory mechanisms is crucial for therapeutic development.
Purpose of the Study:
- To elucidate the gene regulatory mechanisms of IL-1β and EGF.
- To analyze the signaling pathways involving transcription factors NFκB and Elk-1.
- To explore the connection between aberrant EGF signaling, inflammation, and cancer development.
Main Methods:
- Literature review focusing on molecular mechanisms.
- Analysis of signaling cascades initiated by IL-1β and EGF.
- Examination of receptor-mediated cellular responses.
Main Results:
- IL-1β and EGF activate distinct and overlapping signaling pathways.
- Both cytokines converge on transcription factors like NFκB and Elk-1.
- Aberrant signaling in the EGF receptor family is linked to cancer progression.
Conclusions:
- IL-1β and EGF play critical roles in gene regulation relevant to inflammation and cancer.
- The interplay between inflammation and EGF signaling contributes to tumorigenesis.
- Targeting these pathways may offer therapeutic strategies for cancer.
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Regulation of Angiogenesis and Blood Supply
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
